A bibliometric analysis of oncolytic virotherapy combined with immunotherapy

被引：0
作者：
Zhang, Ting [1 ]
Jiang, Shitao [1 ]
Zhang, Lei [1 ]
Liu, Yaoge [1 ]
Zheng, Han [1 ]
Zhao, Haitao [1 ]
Du, Shunda [1 ]
Xu, Yiyao [1 ]
Lu, Xin [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Liver Surg, State Key Lab Complex Severe & Rare Dis, 1 Shuaifuyuan, Beijing 100730, Peoples R China
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2024年 / 20卷 / 01期
关键词：
Oncolytic virotherapy; immunotherapy; bibliometrics; VOSviewer; CiteSpace; COMBINATION; CHECKPOINT; NIVOLUMAB;
D O I：
10.1080/21645515.2024.2406621
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Oncolytic virotherapy in combination with immunotherapy has demonstrated significant survival benefits in some types of cancer. Here, we summarized the development, research hotpots and potential trends of the combination therapy using visual bibliometric analysis. A total of 712 articles were retrieved on June 21, 2023. The USA was the top contributors of any country (325, 45.65%), and the Rluk Research Libraries UK ranked first (43, 6.03%) of any institutions. The Journal for ImmunoTherapy of Cancer was with the largest publications (60, 8.43%). 'Tumor microenvironment' and 'delivery' were citation keywords with the strongest ongoing bursts. Research fronts in the future may focus on the methods of virus delivery and tumor microenvironment modulation. Futhermore, the most extensively studied cancer were melanoma, glioma and hepatocellular carcinoma.
引用
收藏
页数：8
相关论文
共 34 条
  • [1] Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
    Andtbacka, Robert H. I.
    Kaufman, Howard L.
    Collichio, Frances
    Amatruda, Thomas
    Senzer, Neil
    Chesney, Jason
    Delman, Keith A.
    Spitler, Lynn E.
    Puzanov, Igor
    Agarwala, Sanjiv S.
    Milhem, Mohammed
    Cranmer, Lee
    Curti, Brendan
    Lewis, Karl
    Ross, Merrick
    Guthrie, Troy
    Linette, Gerald P.
    Daniels, Gregory A.
    Harrington, Kevin
    Middleton, Mark R.
    Miller, Wilson H., Jr.
    Zager, Jonathan S.
    Ye, Yining
    Yao, Bin
    Li, Ai
    Doleman, Susan
    VanderWalde, Ari
    Gansert, Jennifer
    Coffin, Robert S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (25) : 2780 - U98
  • [2] The relationship between the research performance of scientists and their position in co-authorship networks in three fields
    Bordons, Maria
    Aparicio, Javier
    Gonzalez-Albo, Borja
    Diaz-Faes, Adrian A.
    [J]. JOURNAL OF INFORMETRICS, 2015, 9 (01) : 135 - 144
  • [3] Borghaei H, 2021, J CLIN ONCOL, V39, P723, DOI 10.1200/JCO.20.01605
  • [4] CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific literature
    Chen, CM
    [J]. JOURNAL OF THE AMERICAN SOCIETY FOR INFORMATION SCIENCE AND TECHNOLOGY, 2006, 57 (03): : 359 - 377
  • [5] The expansion of Google Scholar versus Web of Science: a longitudinal study
    de Winter, Joost C. F.
    Zadpoor, Amir A.
    Dodou, Dimitra
    [J]. SCIENTOMETRICS, 2014, 98 (02) : 1547 - 1565
  • [6] Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virus
    Diaz, Rosa Maria
    Galivo, Feorillo
    Kottke, Timothy
    Wongthida, Phonphimon
    Qiao, Jian
    Thompson, Jill
    Valdes, Mikael
    Barber, Glen
    Vile, Richard G.
    [J]. CANCER RESEARCH, 2007, 67 (06) : 2840 - 2848
  • [7] Evolutionary conflicts between viruses and restriction factors shape immunity
    Duggal, Nisha K.
    Emerman, Michael
    [J]. NATURE REVIEWS IMMUNOLOGY, 2012, 12 (10) : 687 - 695
  • [8] CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy
    Engeland, Christine E.
    Grossardt, Christian
    Veinaide, Ruta
    Bossow, Sascha
    Lutz, Diana
    Kaufmann, Johanna K.
    Shevchenko, Ivan
    Umansky, Viktor
    Nettelbeck, Dirk M.
    Weichert, Wilko
    Jaeger, Dirk
    von Katie, Christof
    Ungerechts, Guy
    [J]. MOLECULAR THERAPY, 2014, 22 (11) : 1949 - 1959
  • [9] NF-κB c-Rel Is Crucial for the Regulatory T Cell Immune Checkpoint in Cancer
    Grinberg-Bleyer, Yenkel
    Oh, Hyunju
    Desrichard, Alexis
    Bhatt, Dev M.
    Caron, Rachel
    Chan, Timothy A.
    Schmid, Roland M.
    Klein, Ulf
    Hayden, Matthew S.
    Ghosh, Sankar
    [J]. CELL, 2017, 170 (06) : 1096 - 1108
  • [10] Optimizing oncolytic virotherapy in cancer treatment
    Harrington, Kevin
    Freeman, Daniel J.
    Kelly, Beth
    Harper, James
    Soria, Jean-Charles
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (09) : 689 - 706
1234